Catechol Thioethers in Parkinson's Disease

This study has been completed.
Information provided by:
National Institute of Environmental Health Sciences (NIEHS) Identifier:
First received: August 5, 2002
Last updated: March 22, 2006
Last verified: March 2006

The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.

Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Natural History
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by National Institute of Environmental Health Sciences (NIEHS):

Estimated Enrollment: 20
Study Start Date: March 2001
Estimated Study Completion Date: March 2002

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

First diagnosis of Parkinson's disease.

  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided Identifier: NCT00042692     History of Changes
Other Study ID Numbers: 10196-CP-001
Study First Received: August 5, 2002
Last Updated: March 22, 2006
Health Authority: United States: Federal Government

Keywords provided by National Institute of Environmental Health Sciences (NIEHS):
catechol thioethers
Parkinson's disease
neurodegenerative disease

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases processed this record on April 16, 2014